Groundbreaking Medical Laser Technology

Theralase® is a clinical stage pharmaceutical company headquartered in Toronto, Canada.

TLT : TSX.V  |  TLTFF : OTCQX

Cool Laser Technology (“CLT”) Division

Photo Dynamic Therapy (“PDT”) Division

Investment Highlights

Design, manufacture and distribution of patented and proprietary super-pulsed CLT for the treatment of knee pain, and in off-label use, the treatment of numerous nerve, muscle and joint conditions.

Focused on the research and development of light activated Photo Dynamic Compounds and their associated drug formulations intended to safely and effectively destroy various cancers.

Proven Technology

Strong Intellectual Property

Experienced Management Team

Proven safety and effectiveness of CLT via a blinded randomized controlled clinical study in the treatment of knee pain.

Theralase® has 15 issued patents for its CLT and PDT Divisions covering its core technologies, as well as an additional 34 patents pending.

For 25 years, Theralase® has set the standard for medical laser innovation in the health care sector

The experienced management team has teamed up with scientific researchers, chemists, physicists and medical doctors from renowned research hospitals and academic institutions around the world to focus on developing cutting-edge technologies able to destroy cancer and eliminate pain.

As Seen on:

"Many solid cancers are going to be treatable with this technology. 

There are many other opportunities here." 

-  Dr. Michael Jewett - Professor of Surgery, University of Toronto

Copyright © 2018. All rights reserved.

Presented By: